Arcus Biosciences (RCUS) Treasury Shares (2016 - 2025)

Arcus Biosciences' Treasury Shares history runs 10 years deep, the most recent figure standing at $2.9 million for Q4 2025.

• In Q4 2025, Treasury Shares rose 31.82% year-over-year to $2.9 million; the TTM figure through Dec 2025 stood at $2.9 million (up 31.82% YoY), while the FY2025 annual figure was $2.9 million, up 31.82% from the prior year.
• Treasury Shares was $2.9 million for Q4 2025 at Arcus Biosciences, up from $2.2 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.9 million in Q4 2025 to a low of $1.1 million in Q4 2021.
• Historically, Treasury Shares has averaged $1.8 million across 5 years, with a median of $1.5 million in 2023.
• The sharpest annual moves came in 2021 and 2023: Treasury Shares soared 48.92% in 2021, then advanced 15.38% in 2023.
• A 5-year view of Treasury Shares shows it stood at $1.1 million in 2021, then increased by 18.18% to $1.3 million in 2022, then gained by 15.38% to $1.5 million in 2023, then surged by 46.67% to $2.2 million in 2024, then jumped by 31.82% to $2.9 million in 2025.
• The last three Treasury Shares figures came in at $2.9 million (Q4 2025), $2.2 million (Q4 2024), and $1.5 million (Q4 2023), per Business Quant data.